CABALETTA BIO, INC. (CABA): Price and Financial Metrics

CABALETTA BIO, INC. (CABA): $1.67

0.01 (-0.60%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CABA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#279 of 307

in industry

CABA Price/Volume Stats

Current price $1.67 52-week high $7.46
Prev. close $1.68 52-week low $0.99
Day low $1.67 Volume 623,000
Day high $1.73 Avg. volume 1,597,161
50-day MA $1.76 Dividend yield N/A
200-day MA $0.00 Market Cap 84.74M

CABA Stock Price Chart Interactive Chart >


CABALETTA BIO, INC. (CABA) Company Bio


Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.


CABA Latest News Stream


Event/Time News Detail
Loading, please wait...

CABA Latest Social Stream


Loading social stream, please wait...

View Full CABA Social Stream

CABA Price Returns

1-mo -6.70%
3-mo 30.47%
6-mo -34.25%
1-year -76.45%
3-year 18.44%
5-year -86.97%
YTD -26.43%
2024 -90.00%
2023 145.41%
2022 144.06%
2021 -69.63%
2020 -10.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!